Premium
Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single‐centre analysis
Author(s) -
Lauer Eliza M.,
Waterhouse Miguel,
Braig Moritz,
Mutter Jurik,
Bleul Sabine,
DuqueAfonso Jesús,
Duyster Justus,
Marks Reinhard,
Reinacher Peter C.,
Prinz Marco,
Illerhaus Gerald,
Finke Jürgen,
Schorb Elisabeth,
Scherer Florian
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16759
Subject(s) - ibrutinib , medicine , salvage therapy , oncology , bruton's tyrosine kinase , progression free survival , primary central nervous system lymphoma , rituximab , lymphoma , chemotherapy , tyrosine kinase , leukemia , receptor , chronic lymphocytic leukemia